Head and neck cancer post-treatment clinical pathways for patients and relatives: hospital and patient organisations collaboration – feasibility study
[...]to our knowledge, this system has never been deployed in HNC. Since 2012, the cancer announcement process has been generalised at our institution for patients with HNC. All patients are offered a time of pretherapeutic paramedical support (called ‘temps d’accompagnement soignant 1’ (TAS 1), tha...
Saved in:
Published in | BMJ supportive & palliative care Vol. 14; no. e1; pp. e324 - e325 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
British Medical Journal Publishing Group
27.07.2022
BMJ Publishing Group LTD BMJ Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...]to our knowledge, this system has never been deployed in HNC. Since 2012, the cancer announcement process has been generalised at our institution for patients with HNC. All patients are offered a time of pretherapeutic paramedical support (called ‘temps d’accompagnement soignant 1’ (TAS 1), that is, time for support by caregiver). Since June 2019, a work on post cancer is being conducted by our hospital, the Instance de Promotion et d'Education Pour la Santé Auvergne Rhône Alpes and five patient associations (Association des Mutilés de la Voix Rhône Alpes, Ligues de Lutte Contre le Cancer d'Ardèche et de la Drôme, Agir Contre le Cancer 26 and Cancer et Activité Physique Drôme Ardèche) allowing the networking of different key actors of the territory to improve the overall health of patients. Since October 2021, we have implemented the feasibility of a post-HNC health pathway and of which we present the main steps, tools and results. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 2045-435X 2045-4368 |
DOI: | 10.1136/spcare-2022-003843 |